Yes and no.
Allowing small businesses to band together to self insure (part of the Ryan plan) is something that, I believe, isn't in the House plan but in the Senate one. This part is interesting because it has potential to lower small business insurance costs significantly, but will also affect state revenues (because states can't tax these types of plans). It might have a big impact on how many businesses offer health insurance. Implementing this effectively is up to the Dept of Labor-- they'll need to develop the expertise to do this in a pretty short period of time. This is good for small businesses, but could create a lot of problems for states and for the individual markets (because it may raise the risk profile of this section of the market).
If I remember right, the House bill mandates that interstate health insurance sales be allowed, but I don't think the Senate bill does. I hope not-- mandated interstate health insurance sales is a terrible idea.
Neither the House or Senate version do much to eliminate defensive medicine or limit liability.
A lot of the stuff about drug development is in the hands of the FDA, and Commissioner Gottlieb is saying all the right things.
Does either plan do anything that really bends the cost curve down while focusing on quality? Not really.
A lot of the success of either plan is going to come from how well executive agencies perform, and there is a lot of room for improvement.